Concepedia

Publication | Open Access

Comparative Risks of Infection With Belimumab Versus Oral Immunosuppressants in Patients With Nonrenal Systemic Lupus Erythematosus

DOIFull Paper Access

27

Citations

26

References

2023

Year

Emma Materne, Hyon K. Choi, Baijun Zhou, Karen H. Costenbader, Yuqing Zhang, April Jorge
Arthritis & Rheumatology

Abstract

Belimumab was associated with lower risks of serious infection than with oral immunosuppressants. This finding should inform risk/benefit considerations for SLE treatment.

References

YearCitations

Page 1